Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
NCT ID: NCT00067158
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
585 participants
INTERVENTIONAL
2003-04-30
2004-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Nicotine Agents for Smoking Cessation
NCT00108537
Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)
NCT00326781
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
NCT00158171
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
NCT03178422
Tobacco Cessation in Postmenopausal Women (Part II) - 2
NCT00061074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nicotine transdermal system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Use of smokeless tobacco
* Use of other smoking cessasation product
* Pregnancy
* Patient has hyper-tension, heart problems, or skin condition
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
New York University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malcolm Reid, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
New York University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Matrix Institute on Addictions
Los Angeles, California, United States
Tarzana Treatment Center
Tarzana, California, United States
SPECTRUM
Miami, Florida, United States
Center for Drug Free Living
Orlando, Florida, United States
Chelsea Arbor Addictions Treatment Center
Ann Arbor, Michigan, United States
Psychiatry and Behavioral Medicine Professionals I
Detroit, Michigan, United States
Narco Freedom (Bridge Plaza)
Long Island City, New York, United States
St. Luke's Roosevelt Hospital Center
New York, New York, United States
St. Luke's Roosevelt Hospital Center, Womens
New York, New York, United States
Mount Sinai Medical Center
New York, New York, United States
Piedmont Behavioral Healthcare
Concord, North Carolina, United States
Coastal Horizons Center, Inc.
Wilmington, North Carolina, United States
Behavioral Health Services of Pickens County
Pickens, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTN-0009-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.